Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
RSS

GE Healthcare and Takeda form liver fibrosis imaging collaboration

Nov. 12, 2014

Alion and Medical Prognosis Institute to identify response biomarkers for ion channel inhibitor

Nov. 7, 2014

Fujifilm to invest in PET radiopharmaceuticals

Nov. 7, 2014

Qiagen to develop companion diagnostics for Astellas drugs

Oct. 31, 2014

Chembio Diagnostics signs agreements to develop POC diagnostic tests for Ebola, dengue and cancer

Oct. 29, 2014

First-in-human results presented for radiolabeled antibody [68Ga]ABY-025

Oct. 27, 2014

Kinetic analysis of the new PET ligand [11C]Lu-AE-92686

Oct. 27, 2014

[18F]Fludarabine: a highly sensitive and specific radiotracer for lymphoma

Oct. 24, 2014

In vivo testing of novel GPR-directed [99mTc]demobesin mimics

Oct. 23, 2014

Pivotal study begins of BreathID test for clinically significant portal hypertension

Oct. 22, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...